Patients with symmetric Parkinson's disease do poorly with subthalamic stimulation.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jost Stefanie Theresa, Atwani Camilla, Loehrer Philipp Alexander, Ashkan Keyoumars, Rizos Alexandra, Petry-Schmelzer Jan Niklas, Krauss Jonas, Krause Jan F, Konitsioti Agni Maria, Biundo Roberta, Pedrosa David J, Evans Julian, Visser-Vandewalle Veerle, Nimsky Christopher, Fink Gereon Rudolf, Silverdale Monty, Fasano Alfonso, Martinez-Martin Pablo, Antonini Angelo, Borghammer Per, Ray Chaudhuri K, Timmermann Lars, Dafsari Haidar S, Non-Motor Parkinson’s Disease Research Group, German Parkinson Society Non-Motor Symptoms Study Group, Movement Disorders Society Non-Motor Parkinson’s Disease Study Group
Аннотация
METHODS: This was a prospective, quasi-experimental, non-randomised, controlled, international multicentre study with a 6-month follow-up. The primary outcome was the Scales for Outcomes in Parkinson's Disease-Motor ADL scale. Secondary outcomes included Unified Parkinson's Disease Rating Scale motor examination and Parkinson's Disease Questionnaire-8 (PDQ-8). We defined symmetric PD as a right-to-left hemibody motor score equalling 1. We analysed within-group longitudinal changes, between-group outcome differences, effect size and correlations between PDQ-8 and motor changes. We confirmed results in a propensity-score matched subcohort with well-balanced demographic and clinical parameters.
RESULTS: We included 200 patients with asymmetric and 54 with symmetric PD. In symmetric PD, ADL remained stable, which was not associated with the observed PDQ-8 improvement. In contrast, in asymmetric PD, ADL improved with a moderate effect size, which correlated moderately with PDQ-8 improvement. In symmetric PD, the absolute risk of experiencing no clinically relevant postoperative ADL improvement was 23.8% higher.
CONCLUSIONS: This study provides class IIb evidence of worse ADL outcome of STN-DBS in patients with symmetric compared with asymmetric PD. Clinicians should counsel patients with symmetric PD on their elevated risk of ADL non-response when discussing STN-DBS as a treatment option.